受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:D4039
Praluzatamab ravtansine (CX-2009) is a conditionally activated Probody drug conjugate (PDC) comprising an anti-CD166 mAb conjugated to DM4, with a protease-cleavable linker and a peptide mask that limits target engagement in normal tissue and circulation.
CAS No. | 2145115-85-9 |
---|---|
Formulation | 1xPBS |
ADC antiody | Praluzatamab |
ADC cytotoxin | DM4 |
Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
Shipping | Shipped under low temperature conditions |
人間や獣医の診断であるか治療的な使用のためにでない。